Article Versions Notes

Ormond KE, Borensztein MJ, Hallquist MLG, Buchanan AH, Faucett WA, Peay HL, Smith ME, Tricou EP, Uhlmann WR, Wain KE, et al. Defining the Critical Components of Informed Consent for Genetic Testing. Journal of Personalized Medicine. 2021; 11(12):1304. https://doi.org/10.3390/jpm11121304

Ormond, Kelly E., Maia J. Borensztein, Miranda L. G. Hallquist, Adam H. Buchanan, William Andrew Faucett, Holly L. Peay, Maureen E. Smith, Eric P. Tricou, Wendy R. Uhlmann, Karen E. Wain, and et al. 2021. "Defining the Critical Components of Informed Consent for Genetic Testing" Journal of Personalized Medicine 11, no. 12: 1304. https://doi.org/10.3390/jpm11121304

Ormond, K. E., Borensztein, M. J., Hallquist, M. L. G., Buchanan, A. H., Faucett, W. A., Peay, H. L., Smith, M. E., Tricou, E. P., Uhlmann, W. R., Wain, K. E., Coughlin, C. R., II, & On behalf of the Clinical Genome CADRe Workgroup. (2021). Defining the Critical Components of Informed Consent for Genetic Testing. Journal of Personalized Medicine, 11(12), 1304. https://doi.org/10.3390/jpm11121304